With latest 18-month data cut, Takeda pushes toward 2021 launch of dengue vaccine — can they sidestep Sanofi's disaster?
Takeda’s dengue vaccine has passed the second of a three-part late-stage test, the company says, buffing up a data package that they expect to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
